Toshiba opens $3M MR center to support research + training

Lisa Fratt | | Health Exec | Precision Medicine
Toshiba America Medical Systems has opened the Toshiba MR Research Center in Irvine, Calif.

The $3 million project is designed to be a catalyst for advancing customer training and research, according to Toshiba.

Toshiba’s MR Research Center allows domestic and international customers to use the Toshiba MR systems, including the Vantage Titan 3T wide-bore MR and various Vantage Titan 1.5T MR system configurations. Toshiba will rotate and upgrade technology annually to offer the current MR systems and software.

The training experience is tailored to meet specific customer needs, allowing customers to test the protocols most often used and learn new imaging techniques. The MR Research Center also provides potential customers the opportunity to experience the Toshiba technology configurations that they are considering for purchase. 

Lisa Fratt

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.